Literature DB >> 21323242

Initial visual field as a predictor of recurrence and postoperative visual outcome in children with craniopharyngioma.

Min Joung Lee1, Jeong-Min Hwang.   

Abstract

PURPOSE: The aim of this study was to investigate the significance of the initial visual field as a predictor of recurrence of craniopharyngioma and postoperative visual outcome in children with craniopharyngioma.
METHODS: A retrospective analysis was performed on 27 children 15 years of age or younger with craniopharyngioma. Records of clinical features including ocular and systemic symptoms, optic disc findings, and size of the tumor were analyzed according to preoperative visual field. Postoperative visual acuities, visual fields, and recurrence rates were also evaluated.
RESULTS: Preoperatively, 13 patients had a normal visual field and 14 patients had various visual field defects. The size of the tumor was not correlated with the preoperative visual field defects (P = .15). Preoperative visual field defects were associated with polyuria and polydipsia (P = .01), higher recurrence (P < .001), and poorer postoperative visual acuities (P < .001).
CONCLUSION: Preoperative visual field can be a reliable clinical indicator of systemic manifestations, recurrence, and postoperative visual outcome in children with craniopharyngioma. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21323242     DOI: 10.3928/01913913-20110208-03

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

1.  Excision of pediatric craniopharyngioma: pattern of recurrence in 35 patients at a tertiary care hospital in Saudi Arabia.

Authors:  Essam Al Shail; Ahmad Al-Shenkiti; Mohammad T Alotaibi; Khawar Siddiqui; Amani Al-Kofide
Journal:  Childs Nerv Syst       Date:  2019-09-03       Impact factor: 1.475

2.  The ophthalmic natural history of paediatric craniopharyngioma: a long-term review.

Authors:  Evangelos Drimtzias; Kevin Falzon; Susan Picton; Irfan Jeeva; Danielle Guy; Olwyn Nelson; Ian Simmons
Journal:  J Neurooncol       Date:  2014-08-31       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.